Uncovering the Missing Link that Determines Susceptibility to Autoimmunity

发现决定自身免疫易感性的缺失环节

基本信息

  • 批准号:
    7939802
  • 负责人:
  • 金额:
    $ 94.45万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2009
  • 资助国家:
    美国
  • 起止时间:
    2009-09-30 至 2014-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION Abstract Autoimmunity is a self-destructive immune disorder and often directed towards a particular tissue or organ. Although the disease manifestations can be tissue-specific, they do not necessarily originate in that particular tissue. Furthermore, individuals with a specific autoimmune disease are at risk to develop additional autoimmunity directed towards other target tissues. What all autoimmune diseases do have in common is that they result from a breakdown in self-tolerance, with a major contribution from pathogenic self-reactive T cells. T cell tolerance towards "self" is initially established in the thymus during the process of thymic selection. Strong self-reactive T cells are either clonally deleted or alternatively clonally deviated to become regulatory T cells that are key suppressors of auto-aggressive immune cells. Since this decisive selection process plays a fundamental role in self-tolerance, we postulate that susceptibility to autoimmunity might originate from a principal defect in the central process that governs clonal deletion versus clonal deviation. The proposal will test this hypothesis and ultimately seek to identify the primary deficiency and contributing factors that underlie susceptibility to autoimmunity. Understanding the defect(s) is this selection process will ultimately allow for early detection of individuals that are at a high risk to develop autoimmune diseases. Aside from detecting autoimmune susceptibility, this research will have vital implications for the prevention and effective treatment of autoimmune diseases. Although it is feasible to induce the production of suppressive regulatory T cells through immunization with self antigens, it is possible that pathogenic self-reactive cells will be generated, thus exacerbating the disease. Our proposed study will explore a novel strategy to prevent and/or treat autoimmunity. Hepatic stellate cells will be used as natural, regulatory, antigen-presenting cells to assure the efficient ge
描述 摘要 自身免疫是一种自我破坏性的免疫疾病,通常针对特定的组织或器官。虽然疾病表现可以是组织特异性的,但它们不一定起源于该特定组织。此外,患有特定自身免疫性疾病的个体有风险发展针对其他靶组织的额外自身免疫性。所有自身免疫性疾病的共同点是,它们都是由自身耐受性的破坏引起的,其中致病性自身反应性T细胞起了主要作用。T细胞对“自身”的耐受性最初是在胸腺选择过程中在胸腺中建立的。强的自身反应性T细胞被克隆删除或克隆偏离,成为调节性T细胞,其是自身攻击性免疫细胞的关键抑制因子。由于这种决定性的选择过程中发挥了重要作用,自我耐受性,我们假设,自身免疫的易感性可能源于一个主要的缺陷,在中央过程中,管理克隆缺失与克隆偏差。该提案将测试这一假设,并最终寻求确定原发性缺陷和导致自身免疫易感性的因素。了解缺陷是这种选择过程最终将允许早期检测处于高风险发展自身免疫性疾病的个体。除了检测自身免疫易感性,这项研究将对预防和有效治疗自身免疫性疾病具有重要意义。尽管通过自身抗原免疫诱导抑制性调节性T细胞的产生是可行的,但也有可能产生致病性自身反应细胞,从而加剧疾病。我们提出的研究将探索一种新的策略来预防和/或治疗自身免疫。肝星状细胞将作为天然的、调节性的、抗原提呈细胞,以保证肝细胞的有效分化。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

HILDE MC CHEROUTRE其他文献

HILDE MC CHEROUTRE的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('HILDE MC CHEROUTRE', 18)}}的其他基金

The Role of Cytoplasmic and Nuclear THEMIS in Immature and Mature T cells
细胞质和细胞核 THEMIS 在未成熟和成熟 T 细胞中的作用
  • 批准号:
    10331846
  • 财政年份:
    2020
  • 资助金额:
    $ 94.45万
  • 项目类别:
The Role of Cytoplasmic and Nuclear THEMIS in Immature and Mature T cells
细胞质和细胞核 THEMIS 在未成熟和成熟 T 细胞中的作用
  • 批准号:
    9888243
  • 财政年份:
    2020
  • 资助金额:
    $ 94.45万
  • 项目类别:
The Role of Cytoplasmic and Nuclear THEMIS in Immature and Mature T cells
细胞质和细胞核 THEMIS 在未成熟和成熟 T 细胞中的作用
  • 批准号:
    10552636
  • 财政年份:
    2020
  • 资助金额:
    $ 94.45万
  • 项目类别:
Control of the Functional Fate of CD4 T Cells by LncRNA-Switch
LncRNA-Switch 对 CD4 T 细胞功能命运的控制
  • 批准号:
    9170246
  • 财政年份:
    2016
  • 资助金额:
    $ 94.45万
  • 项目类别:
DIFFERENTIATION AND ANTI-VIRAL PROTECTIVE AND PATHOGENIC ROLES OF CD4 CTL
CD4 CTL 的分化、抗病毒保护和致病作用
  • 批准号:
    9246417
  • 财政年份:
    2014
  • 资助金额:
    $ 94.45万
  • 项目类别:
DIFFERENTIATION AND ANTI-VIRAL PROTECTIVE AND PATHOGENIC ROLES OF CD4 CTL
CD4 CTL 的分化、抗病毒保护和致病作用
  • 批准号:
    8655464
  • 财政年份:
    2014
  • 资助金额:
    $ 94.45万
  • 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
  • 批准号:
    8518428
  • 财政年份:
    2009
  • 资助金额:
    $ 94.45万
  • 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
  • 批准号:
    7846264
  • 财政年份:
    2009
  • 资助金额:
    $ 94.45万
  • 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
  • 批准号:
    8134362
  • 财政年份:
    2009
  • 资助金额:
    $ 94.45万
  • 项目类别:
Uncovering the Missing Link that Determines Susceptibility to Autoimmunity
发现决定自身免疫易感性的缺失环节
  • 批准号:
    8318169
  • 财政年份:
    2009
  • 资助金额:
    $ 94.45万
  • 项目类别:

相似海外基金

Engineered TCR-Treg Cell Therapies Targeting Type 1 Diabetes Autoantigens
针对 1 型糖尿病自身抗原的工程化 TCR-Treg 细胞疗法
  • 批准号:
    10764143
  • 财政年份:
    2023
  • 资助金额:
    $ 94.45万
  • 项目类别:
Study of identification for autoantigens in a mouse model of pituitary dysfunction induced by CTLA-4 or PD-1 blockade
CTLA-4或PD-1阻断诱导的垂体功能障碍小鼠模型中自身抗原的鉴定研究
  • 批准号:
    22K08648
  • 财政年份:
    2022
  • 资助金额:
    $ 94.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Engineered TCR-Treg Cell Therapies Targeting Type 1 Diabetes Autoantigens
针对 1 型糖尿病自身抗原的工程化 TCR-Treg 细胞疗法
  • 批准号:
    10545634
  • 财政年份:
    2022
  • 资助金额:
    $ 94.45万
  • 项目类别:
identification of autoantigens of autoimmune pancreatitis
自身免疫性胰腺炎自身抗原的鉴定
  • 批准号:
    21H02901
  • 财政年份:
    2021
  • 资助金额:
    $ 94.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Genetic Basis of Variable Expression of Glycan Xeno-Autoantigens by Cattle
牛聚糖异种自身抗原变异表达的遗传基础
  • 批准号:
    DP200103734
  • 财政年份:
    2020
  • 资助金额:
    $ 94.45万
  • 项目类别:
    Discovery Projects
The study to identify novel pathogenesis and autoantigens in patients with membranous nephropathy
确定膜性肾病患者新发病机制和自身抗原的研究
  • 批准号:
    19K08694
  • 财政年份:
    2019
  • 资助金额:
    $ 94.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Project 3-Proteomic Analysis of Explanted Livers with characterization of Autoantigens
项目 3 - 外植肝脏的蛋白质组学分析及自身抗原的表征
  • 批准号:
    10356015
  • 财政年份:
    2019
  • 资助金额:
    $ 94.45万
  • 项目类别:
Project 3-Proteomic Analysis of Explanted Livers with characterization of Autoantigens
项目 3 - 外植肝脏的蛋白质组学分析及自身抗原的表征
  • 批准号:
    10560561
  • 财政年份:
    2019
  • 资助金额:
    $ 94.45万
  • 项目类别:
Project 3-Proteomic Analysis of Explanted Livers with characterization of Autoantigens
项目 3 - 外植肝脏的蛋白质组学分析及自身抗原的表征
  • 批准号:
    10093988
  • 财政年份:
    2019
  • 资助金额:
    $ 94.45万
  • 项目类别:
Identification of autoantigens presented by specific HLA class I alleles in aplastic anemia
再生障碍性贫血中特定 HLA I 类等位基因呈现的自身抗原的鉴定
  • 批准号:
    19H03686
  • 财政年份:
    2019
  • 资助金额:
    $ 94.45万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了